Calculated
DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
125.70 USD117.49 USD147.32 USD
+72.1%
117.49 USDCurrent price is 72.1% above the base model value.
A
HealthcareDrug Manufacturers - GeneralUnited States
ABBV.US · AbbVie Inc.
NYQ · US · USD
Latest price202.20 USD
30D+9.76%
Vs. base value+171%
Research summary
ABBV.US latest organized financial period shows revenue grew +8.57% YoY and net income declined -1.22% YoY. Current price is about 202 USD, while the model base case is about 74.69 USD; the current price sits +171% versus the base case. This summary is intended for public-information research and model review.
Key financial trend
Annual financial metrics with switchable views. · Unit: USD
Revenue61B USD
Net income4B USD
Free cash flow18B USD
Operating cash flow19B USD
Price trend
Price date: 2026/04/28 · Updated: 2026/04/29 07:23
Valuation model range
Hover each model row to inspect formulas and inputs.
Current price202.20 USD
Base value74.69 USD
Vs. base+171%
Price date2026/04/28
74.69 USD74.69 USD74.69 USD
+171%
Calculated
Owner Earnings
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
31.44 USD29.38 USD36.84 USD
+588%
29.38 USDCurrent price is 588.1% above the base model value.
Calculated
Reverse DCF
Solves the forward FCF growth rate implied by the current price.
Implied growth5.2%
Current price implies roughly 5.2% annualized FCF growth.
5.2%Current price implies roughly 5.2% annualized FCF growth.
Calculated
Earnings Power Value
Estimates earnings power value without assuming growth.
74.69 USD74.69 USD74.69 USD
+171%
74.69 USDCurrent price is 170.7% above the base model value.
Updated: 2026/04/29 07:23
Ad placement
Quarterly and annual financial table
Financial DetailsShowing latest 5 / 9
| Period | Type | Revenue | Net Income | Free Cash Flow | Diluted EPS |
|---|---|---|---|---|---|
| 2025/12/30 | Annual | 61B USD | 4B USD | 18B USD | 2.37 |
| 2024/12/30 | Annual | 56B USD | 4B USD | 18B USD | 2.39 |
| 2023/12/30 | Annual | 54B USD | 5B USD | 22B USD | 2.72 |
| 2022/12/30 | Annual | 58B USD | 12B USD | 24B USD | 6.63 |
| 2021/12/30 | Annual | - | - | - | - |
Ad placement